Knipper Acquires Sample Management Business from inVentiv Health, Becoming the Largest End-to-End Pharmaceutical Samples Management Service Provider in the U.S.

LAKEWOOD, N.J., Apr 03, 2013 -- J. Knipper and Company, Inc., developing and delivering smart, effective and efficient commercial solutions to the healthcare community, announced yesterday that the Company has acquired the inVentiv Health MySTRO Sample Management and Fulfillment business, including regulatory compliance, sample accountability, and fulfillment services. With this acquisition, J. Knipper and Company becomes the largest end-to-end pharmaceutical samples management service provider in the U.S., dedicated to the pharmaceutical and biotech industry with services spanning all phases of the product lifecycle. These services include marketing, printing, sample and literature distribution, eSampling and direct HCP fulfillment, regulatory compliance, information technology, salesforce productivity, and provider data management.

J. Knipper and Company and inVentiv Health will work collaboratively to offer their respective core services and an integrated account management approach to shared customers. The collaboration will allow for J. Knipper and Company to offer Sample Management and Fulfillment services in support of InVentiv Health Selling Solutions Representatives while InVentiv Health will offer tele detailing services to Knipper Multi Channel Programs. Terms of the agreement were not disclosed.

"In our never-ending pursuit of world class customer service and satisfaction, J. Knipper and Company will once again substantially increase its investment and enlarge its footprint in the sampling services marketplace, providing efficiencies of scale and augmenting the company's services infrastructure," stated Jim Knipper, co-Founder and CEO of J. Knipper and Company.

Paul Mignon, President of inVentiv Health Selling Solutions, said: "J. Knipper and Company's greater scale in the areas of sample accountability and fulfillment will enhance the services provided to inVentiv Health customers. And similarly, inVentiv Health's best-in-class tele-detailing capabilities - including our state-of-the-art call center, which is staffed by professional, fully trained and dedicated agents - will provide support and value to J. Knipper and Company's clients. We look forward to continuing to collaborate with the J. Knipper and Company team on delivering customer-focused solutions with real results."

Michael J. Laferrera, President and Chief Operating Officer of J. Knipper and Company, commented, "In recognition of the growing need within the pharmaceutical industry to optimize strategies for sample management, I am confident that this acquisition will allow us to enhance our strategic as well as grass roots services by offering an even greater wealth of employee expertise and executional best practices."

Edgemont Capital Partners, a leading healthcare investment banking firm, acted as exclusive advisor to J. Knipper and Company.

About J. Knipper and Company, Inc.

Founded in 1986, J. Knipper and Company, Inc., provides healthcare marketing solutions in direct marketing, sampling, compliance, information technology, and sales force productivity. Going beyond its roots in direct marketing fulfillment and sample distribution, J. Knipper and Company continues to offer innovative solutions to brand marketing and sales force challenges, including (multi-channel solution for white-space coverage), (eSampling platform) and (a growing suite of salesforce ordering and call management services).

The Company has invested considerably in its physical and data infrastructure over the years. Knipper maintains about 350,000 square feet of facilities, including 12,000 for refrigerated product and almost 12,000 for controlled substances, along with an advanced Data Center, fully protected for the secure and safe management of client data and application services. J. Knipper and Company is one of a handful of companies approved as an American Medical Association Database licensee. For more information, visit

About inVentiv Health

inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life. In 40 countries around the world, inVentiv's 13,000 employees help clients rapidly transform promising ideas into commercial reality. inVentiv clients include more than 550 pharmaceutical, biotech and life sciences companies, as well as companies that now see health as part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.